Praxis Precision Medicines announces 1-for-15 reverse stock split effective Nov 28, 2023

Praxis Precision Medicines, Inc.

Board approved final ratio of 1-for-15, within previously authorized range of 1-for-5 to 1-for-25.
Reverse split becomes effective 5:00 p.m. ET on Nov 28, 2023; split-adjusted trading on Nov 29 under ticker PRAX.
No fractional shares will be issued; shareholders receive cash payment based on closing price before effectiveness.
New CUSIP number for common stock post-split: 74006W 207.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.